First-of-its-kind examination shows how widely pharma showers campaign cash at the state level

(By Lev Facher for STAT)

By the time Will Guzzardi, a state legislator in Illinois, called a vote on his controversial drug pricing reform bill, the crowd in the Springfield hearing room had suspiciously thinned. Three committee Democrats were suddenly missing, and, as a result, his bill failed by three votes.  Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply